portfolio detail LambdaVision

Venture Portfolio

LambdaVision

About:
LambdaVision is designing and developing an innovative, protein-based retinal implant that utilizes the light-activated protein bacteriorhodopsin to stimulate the retina of patients suffering from impaired vision or loss of sight due to retinal degenerative diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa (RP).

Website:
www.lambdavision.com

CI Representative:
Daniel Wagner
Managing Director, Investments

back to portfolio